Burden of Kidney Disease, Health-Related Quality of Life, and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program
Edwina A. Brown,Junhui Zhao,Keith McCullough,Douglas S. Fuller,Ana E. Figueiredo,Brian Bieber,Frederic O. Finkelstein,Jenny Shen,Talerngsak Kanjanabuch,Hideki Kawanishi,Ronald L. Pisoni,Jeffrey Perl,PDOPPS Patient Support Working Group,Vanita Jassal,Mizuya Fukasawa,Scott Wilson,Areewan Cheawchanwattana,Wei Fang,Susanne Ljungman
DOI: https://doi.org/10.1053/j.ajkd.2021.02.327
IF: 11.072
2021-10-01
American Journal of Kidney Diseases
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Rationale & Objective</h3><p>Individuals faced with decisions regarding kidney replacement therapy options need information on how dialysis treatments might affect daily activities and quality of life, and what factors might influence the evolution over time of the impact of dialysis on daily activities and quality of life.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Study Design</h3><p>Observational cohort study.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Setting & Participants</h3><p>7,771 HD and PD participants from 6 countries participating in the Peritoneal and Dialysis Outcomes and Practice Patterns Studies (PDOPPS/DOPPS).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Predictors</h3><p>Patient-reported functional status (based on daily living activities), country, demographic and clinical characteristics, and comorbidities.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Outcomes</h3><p>Employment status and patient-reported outcomes (PROs) including Kidney Disease Quality of Life (KDQOL) instrument physical and mental component summary scores [PCS, MCS], kidney disease burden score, and depression symptoms (CES-D score <u>></u>10).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Analytical Approach</h3><p>Linear regression (PCS, MCS, kidney disease burden score); Logistic regression (depression symptoms); adjusted for predictors plus 12 additional comorbidities.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>In both dialysis modalities, Japan had the highest PCS and employment [HD (55%); PD (68%)], whereas the US had the highest MCS score, lowest kidney disease burden, and lowest employment [HD (20%); PD (42%)]. After covariate adjustment, the association of age, sex, vintage, diabetes, and functional status with PROs was similar in both modalities, with females having lower PCS and kidney disease burden scores. Lower functional status (score <11) was strongly associated with lower PCS and MCS scores, a much greater burden of kidney disease, and greater likelihood of depression symptoms (CES-D>10). The median change in KDQOL-based PROs was negligible over 1 year in participants completing at least two annual questionnaires.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Limitations</h3><p>Selection bias due to incomplete survey responses. Generalizability was limited to dialysis populations of included countries.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Variation exists in quality of life, burden of kidney disease, and depression across countries but did not appreciably change over time. Functional status remained one of the strongest predictors of all PROs. Routine assessment of functional status may provide valuable insights for patients and providers in anticipating outcomes and support needs for patients receiving either PD or HD.</p>
urology & nephrology